Quarterly Cashflow Report
Starpharma today released its Appendix 4C – Quarterly Cashflow Report for the period ended 31 March 2019.
Starpharma on Channel Nine News (April 22, 2019)
|
Channel Nine News reported on the launch of VivaGel® BV (Fleurstat BVgel) in Australia and noted it was a world first, novel and non-antibiotic treatment developed in Australia. The report noted BV affects 12 percent of Australian women and if left untreated could lead to infertility, early delivery or miscarriage. |
Read the TV news segment here.
Markets Live: Starpharma shares rise 13 per cent following Australian launch of VivaGel BV
|
The Australian Financial Review reported Starpharma’s share price rose 13 per cent following the company’s announcement that VivaGel® BV was launched nationwide in Australia. The article noted this was the first of many launches for the breakthrough BV product. |
First VivaGel BV launch globally in Australia by Aspen
Starpharma today announced that VivaGel® BV has been officially launched in Australia by Aspen Pharmacare (Aspen) as Fleurstat BVgel. The product has undergone distribution across Australia and is already available in some pharmacies. It will be progressively rolled-out nationally over the coming weeks. This is the first launch of VivaGel® BV in the world and further launches by Mundipharma are expected in Europe in May/June this year.
Starpharma meets with US FDA to discuss VivaGel® BV
Starpharma today announced that a meeting was held with the US FDA overnight as part of the process to clarify and address FDA’s request for confirmatory data prior to the approval of VivaGel® BV in the US. This meeting was attended by senior representatives of Starpharma as well as internationally recognised Key Opinion Leaders in BV, statisticians and the Company’s expert FDA regulatory consultants, which include former senior FDA clinical personnel.
Starpharma Investor Presentation to Goldman Sachs Conference
Starpharma will today present to institutional investors at the Goldman Sachs Tenth Annual Emerging Companies Conference in Sydney.